Predict your next investment

Tailor Bio company logo
HEALTHCARE | Disease Diagnosis
tailor.bio

See what CB Insights has to offer

Stage

Incubator/Accelerator | Alive

About Tailor Bio

Tailor Bio provides clinical decision support to physicians using mutational signatures.

Tailor Bio Headquarter Location

Cambridge, England,

United Kingdom

Latest Tailor Bio News

Startup innovation boost

Jul 1, 2020

Startup innovation boost 02-07-2020  Two cutting-edge startups currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre at Cambridge Judge Business School receive £100,000-plus Innovate UK funding boost. The UK government recently announced that 800 innovative businesses and startups are set to benefit from Innovate UK funding . Two startups – Tailor Bio and medwise.ai – currently on the Accelerate Cambridge programme run by the Entrepreneurship Centre at Cambridge Judge - are among the winners. Oncology diagnostics company Tailor Bio (formerly known as PinPoint Oncology) has secured £67,000 in funding for the Innovate UK category: application of whole-genome sequencing approaches to cancer. The venture is using machine learning to find patterns in tumour DNA which can be used to predict a person’s response to cancer drugs. Their current test uses a biopsy of a patient’s tumour to predict if they will respond to a drug used to treat ovarian cancer. Co-founder Jason Yip said: “I think that under normal circumstances, the startup journey is already incredibly difficult, and with COVID-19, this is made even harder. We’re very privileged that the UK continues to support cutting-edge startups through Innovate UK. We’re excited to receive this support from them, and hope to use the funding to advance precision medicine approaches to cancer.” Medwise.ai has been awarded a UK government grant of £40,000 to further develop their not-for-profit platform to provide the NHS with free and fast official guidelines and best practice – initially and most urgently to treat COVID-19. Their artificial intelligence platform aggregates information from academic journal articles and national guidelines to provide healthcare professionals with the latest information on COVID-19 in a fast and concise format. The service reflects the need for healthcare workers, particularly clinicians who are working outside of their specialist area during the pandemic, to be able to access the knowledge and information they need to treat COVID-19 patients quickly. CEO and Co-founder Dr Keith Tsui said: “Although the number of new COVID-19 cases is falling in the UK, the knowledge we have about the virus and the disease keeps increasing and it’s nearly impossible to keep up with the latest developments. We need to equip health care workers with the latest evidence and guidance, so COVID-19 patients get the best care possible.” Innovate UK is the innovation arm of the UK government. The £40 million government grant was set up to help innovations arising from the coronavirus crisis “while supporting the UK’s next generation of cutting-edge startups – helping to build the businesses of tomorrow and propel their future prosperity.” Find out more

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tailor Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tailor Bio is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,867 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

11,220 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.